Skip to main content
. 2018 Nov 11;2018:7918091. doi: 10.1155/2018/7918091

Figure 2.

Figure 2

1. day, 33. day, M (the protocol M beginning day)—points of evaluation in the study group. (a) Complete peripheral blood cell counts in children with ALL at particular steps of the study protocol and in the control group. (b) Basic biochemical characteristics of children with ALL at particular steps of the study protocol and of the control group.